Research Article
Potential therapeutic benefits of metformin alone and in combination with sitagliptin in the management of type 2 diabetes patients with COVID-19
Pharmaceuticals 15 (11), 1361, 2022
Publication Year
2022
Citations
39
Authors
6
Authors
HM Al-Kuraishy
AI Al-Gareeb
SM Albogami
S Jean-Marc
EH Nadwa
...
Researchers on Platform
More by this author
Adiponectin Signaling as an Immunometabolic Regulator in COVID-19: Mechanistic Insights and Therapeutic Potential
2026
Role of insulin-like growth factor-1/2 and related signaling in parkinson’s disease
2026
The potential role of metformin in multiple sclerosis: good or bad, and what’s the lesson
2026
Autophagy in ischemic stroke: from cellular survival mechanism to pathological damage
2026
5 citations
Targeting of the PI3K/AKT/mTOR signaling pathway in the neurovascular interface in both Alzheimer's disease and atherosclerosis: The potential nexus
2026